SLNO FY 2015 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$387,555

Gross Profit

$34,8729.0% margin

Operating Income

-$12M-3137.6% margin

Net Income

-$16M-4104.8% margin

EPS (Diluted)

$-126.58

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$942,369

Balance Sheet

Total Assets

$8M

Total Liabilities

$5M

Stockholders' Equity

$3M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$387,555	$0	—
Gross Profit	$34,872	$0	—
Operating Income	-$12M	-$5M	-135.7%
Net Income	-$16M	-$14M	-14.7%